Michael Madeja
Institute of Physiology
University of Münster
Münster
Germany
Name/email consistency: high
- Overlapping binding sites of structurally different antiarrhythmics flecainide and propafenone in the subunit interface of potassium channel Kv2.1. Madeja, M., Steffen, W., Mesic, I., Garic, B., Zhorov, B.S. J. Biol. Chem. (2010)
- Molecular site of action of the antiarrhythmic drug propafenone at the voltage-operated potassium channel Kv2.1. Madeja, M., Leicher, T., Friederich, P., Punke, M.A., Haverkamp, W., Musshoff, U., Breithardt, G., Speckmann, E.J. Mol. Pharmacol. (2003)
- Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action?. Madeja, M., Margineanu, D.G., Gorji, A., Siep, E., Boerrigter, P., Klitgaard, H., Speckmann, E.J. Neuropharmacology (2003)
- Reduction of voltage-operated sodium currents by the anticonvulsant drug sulthiame. Madeja, M., Wolf, C., Speckmann, E.J. Brain Res. (2001)